BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26645405)

  • 1. Enhanced brain distribution of carboplatin in a primate model after blood-brain barrier disruption using an implantable ultrasound device.
    Goldwirt L; Canney M; Horodyckid C; Poupon J; Mourah S; Vignot A; Chapelon JY; Carpentier A
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):211-6. PubMed ID: 26645405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
    Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
    J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-induced opening of the blood-brain barrier to enhance temozolomide and irinotecan delivery: an experimental study in rabbits.
    Beccaria K; Canney M; Goldwirt L; Fernandez C; Piquet J; Perier MC; Lafon C; Chapelon JY; Carpentier A
    J Neurosurg; 2016 Jun; 124(6):1602-10. PubMed ID: 26566207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model.
    McDannold N; Zhang Y; Supko JG; Power C; Sun T; Peng C; Vykhodtseva N; Golby AJ; Reardon DA
    Theranostics; 2019; 9(21):6284-6299. PubMed ID: 31534551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
    Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
    Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
    Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
    J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin pharmacokinetics following a single-dose infusion in sulphur-crested cockatoos (Cacatua galerita).
    Filippich LJ; Charles BG; Sutton RH; Bucher AM
    Aust Vet J; 2004 Jun; 82(6):366-9. PubMed ID: 15267096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carboplatin pharmacokinetics in pediatric oncology by means of inductively coupled plasma mass spectrometry.
    Clerico A; Cappelli C; Ragni G; Caroli S; De Ioris MA; Sordi A; Petrucci F; Bocca B; Alimonti A
    Ann Ist Super Sanita; 2006; 42(4):461-8. PubMed ID: 17361071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma.
    Hayden BC; Jockovich ME; Murray TG; Voigt M; Milne P; Kralinger M; Feuer WJ; Hernandez E; Parel JM
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3644-9. PubMed ID: 15452072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.
    Carpentier A; Stupp R; Sonabend AM; Dufour H; Chinot O; Mathon B; Ducray F; Guyotat J; Baize N; Menei P; de Groot J; Weinberg JS; Liu BP; Guemas E; Desseaux C; Schmitt C; Bouchoux G; Canney M; Idbaih A
    Nat Commun; 2024 Feb; 15(1):1650. PubMed ID: 38396134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C; Matsumoto K; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
    Emerich DF; Snodgrass P; Dean R; Agostino M; Hasler B; Pink M; Xiong H; Kim BS; Bartus RT
    Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum distribution in malignant glioma following intraoperative intravenous infusion of carboplatin.
    Whittle IR; Malcolm G; Jodrell DI; Reid M
    Br J Neurosurg; 1999 Apr; 13(2):132-7. PubMed ID: 10616580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opening of the blood-brain barrier with an unfocused ultrasound device in rabbits.
    Beccaria K; Canney M; Goldwirt L; Fernandez C; Adam C; Piquet J; Autret G; Clément O; Lafon C; Chapelon JY; Carpentier A
    J Neurosurg; 2013 Oct; 119(4):887-98. PubMed ID: 23790118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased distribution of carboplatin, an anti-cancer agent, to rat brains with the aid of hyperbaric oxygenation.
    Suzuki Y; Tanaka K; Neghishi D; Shimizu M; Murayama N; Hashimoto T; Yamazaki H
    Xenobiotica; 2008 Dec; 38(12):1471-5. PubMed ID: 18949658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.